CLOV — Clover Health Investments Corp. stock price and chart

CLOV

$4.80+8.11%

as of close, Oct 20, 2026

☾ AH $4.80 +8.11%

Clover Health Investments Corp.Stock · HealthcareRussell 2000 · 0.07% of IWMNasdaq Composite · 0.006% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV

PeersMOHHUMCNCCIELVCVS

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Jun 17, 2020

VolumeEEEEEEEEEEEE

20202022202320252026

2.04.06.08.010.012.014.016.001.0B$4.80

2026-10-20

Price$4.80

MA20$4.45

MA50$3.48

Vol3.5M

What would $1,000 invested in CLOV be worth today? →

CLOV returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $4.80
YTD price return: +104.26%
YTD total return: +104.26%
Next earnings: Nov 4, 2026 · After close
Market cap: 2.5B2020-06 2.7B2026-10 2.5B-6.0% over the window
Enterprise value: 2.4B
Shares outstanding: 531.2M2019-12 87.8M2026-06 531.2M+504.8% over the window
52W low: $1.58
52W high: $5.59
From 52W high: -14.13%
From 52W low: +203.80%
52W range: 80%

Volume

Rel volume: 0.77×
30D volume: 4.5M
30D $ vol: 20.9M

Fundamentals

Sales (ttm): 2.5B2019-12 462.3M2026-06 2.5B+435.8% over the window
Sales/share: $4.662019-12 $5.262026-06 $4.66-11.4% over the window
EPS (ttm): -$0.032019-12 -$4.142026-06 -$0.03-99.2% over the window
FCF (ttm): 74.2M2019-12 -159.9M2026-06 74.2M-146.4% over the window
FCF/share: $0.142019-12 -$1.822026-06 $0.14-107.7% over the window
Book value/share: $0.712019-12 -$0.002026-06 $0.71-352978.6% over the window
Net margin: -0.74%2019-12 -78.7%2026-06 -0.7%-99.1% over the window
ROE: -4.88%2020-09 -200.4%2026-06 -4.9%-97.6% over the window
ROA: -2.55%2020-09 -1.2%2026-06 -2.5%+110.9% over the window
Current ratio: 1.502019-12 0.002026-06 1.50

Growth (CAGR, ttm) · 10Y

Sales: +54.08%2025-06-30 → 2026-06-301.6B → 2.5B (+54.0% total)+419.92%2023-06-30 → 2026-06-3017.6M → 2.5B (+13969.8% total)+21.18%2021-06-30 → 2026-06-30948.1M → 2.5B (+161.2% total)n/a
FCF: n/a+55.45%2023-06-30 → 2026-06-3019.8M → 74.2M (+275.7% total)n/an/a
Shares: +4.35%2025-06-30 → 2026-06-30509M → 531.2M (+4.3% total)+3.49%2023-06-30 → 2026-06-30479.2M → 531.2M (+10.9% total)+5.41%2021-06-30 → 2026-06-30408.2M → 531.2M (+30.1% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +47.66%2025-06-30 → 2026-06-30$3.16 → $4.66 (+47.6% total)+402.37%2023-06-30 → 2026-06-30$0.04 → $4.66 (+12592.6% total)+14.96%2021-06-30 → 2026-06-30$2.32 → $4.66 (+100.7% total)n/a
FCF/share: n/a+50.20%2023-06-30 → 2026-06-30$0.04 → $0.14 (+238.9% total)n/an/a
Book value/share: +4.77%2025-06-30 → 2026-06-30$0.68 → $0.71 (+4.8% total)+0.89%2023-06-30 → 2026-06-30$0.69 → $0.71 (+2.7% total)-1.45%2021-06-30 → 2026-06-30$0.76 → $0.71 (-7.0% total)n/a
Price: +64.44%2025-10-20 → 2026-10-20$2.92 → $4.80 (+64.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+69.29%2023-10-20 → 2026-10-20$0.99 → $4.80 (+385.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-9.35%2021-10-20 → 2026-10-20$7.84 → $4.80 (-38.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +64.44%2025-10-20 → 2026-10-20$2.92 → $4.80 (+64.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+69.29%2023-10-20 → 2026-10-20$0.99 → $4.80 (+385.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-9.35%2021-10-20 → 2026-10-20$7.84 → $4.80 (-38.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -137.8×2020-06 -7.462026-10 -138.85+1761.9% over the window
Fwd P/E: 29.9×
P/S (ttm)Market cap ÷ TTM revenue.: 1.0×2020-06 5.872026-10 1.03-82.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 6.8×2020-06 542.512026-10 6.78-98.8% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 34.4×2020-06 -16.962026-10 34.36-302.5% over the window
EV/Sales (ttm): 1.0×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 2.91%2020-12 -8.0%2026-06 2.7%-133.4% over the window
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-1.1M) ÷ today's market cap ($2.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -0.04%2020-12 0.0%2026-06 -0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-1.1M + TTM dividends $0) ÷ today's market cap ($2.5B). Same caveat as the cash buyback yield.: -0.04%2020-12 0.0%2026-06 -0.0%

Vs own 10Y history

P/S: 56th
P/B: 82nd

Bar = where today’s multiple sits in CLOV’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+8.11%

-0.21%

+7.62%

+6.67%

YTD

+104.26%

+64.38%

-38.78%

Financial statements

Open full CLOV financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

CLOV — Clover Health Investments Corp. price, chart and key statistics